Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.59M | 6.41M | 6.34M | 6.43M | 6.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.59M | 6.41M | 6.34M | 6.43M | 6.55M |
| Cost of Revenue | 4.01M | 3.97M | 3.90M | 3.99M | 3.94M |
| Gross Profit | 2.57M | 2.43M | 2.44M | 2.44M | 2.61M |
| SG&A Expenses | 2.20M | 2.08M | 2.05M | 2.11M | 2.10M |
| Depreciation & Amortization | 148.40K | 146.20K | 138.90K | 150.30K | 189.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.36M | 6.20M | 6.09M | 6.24M | 6.23M |
| Operating Income | 221.20K | 208.10K | 247.70K | 186.70K | 317.90K |
| Income Before Tax | 1.08M | -148.00K | 318.60K | 560.30K | -1.21M |
| Income Tax Expenses | 194.80K | 59.90K | 91.60K | 87.20K | -256.10K |
| Earnings from Continuing Operations | 886.30K | -207.90K | 227.00K | 473.10K | -954.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 886.30K | -207.90K | 227.00K | 473.10K | -954.70K |
| EBIT | 221.20K | 208.10K | 247.70K | 186.70K | 317.90K |
| EBITDA | 290.70K | 354.30K | 386.60K | 337.00K | 451.50K |
| EPS Basic | 0.01 | 0.00 | 0.00 | 0.01 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | 0.00 | 0.01 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 86.35M | 86.21M | 87.53M | 87.34M | 86.21M |
| Average Diluted Shares Outstanding | 86.35M | 87.47M | 87.53M | 87.34M | 86.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |